BlueDop Medical is an innovative medical
technology company that has developed a novel
approach to detecting vascular disease,
particularly in the lower limbs. Our flagship
product, BlueDop, offers a more efficient and
accurate alternative to traditional Ankle Brachial
Index (ABPI) screening methods.

Our Journey

Leadership Team

We are guided by a team of experienced leaders with diverse expertise across clinical, regulatory, and commercial sectors. Each member brings a wealth of knowledge and a deep commitment to advancing healthcare technologies and improving patient outcomes.

Ciaran McCourt

CHIEF EXECUTIVE OFFICER

Ciaran is the CEO at BlueDop Medical, leveraging over 30 years of experience in healthcare, clinical leadership, and business development to steer the company’s growth and innovation. Ciaran has delivered scale, strong exits, and international growth for multiple companies. Highlights include selling eDiets to Tesco UK, steering strategy at BiancaMed, leading the Ectosense acquisition by ResMed, and recently steering strategic operations at moveUP.

Ciaran is renowned for integrating multidisciplinary R&D, clinical, and commercial teams across Europe and the US, navigating diverse regulatory environments, and introducing market-driven financial discipline. His ability to manage complex transitions and execute commercial strategies underpins BlueDop’s robust market entry plan.

Dr Redmond B. Shouldice

CHIEF OPERATING OFFICER

Redmond Shouldice MBA PhD CEng SMIEEE serves as the Chief Operating Officer at BlueDop Medical, where he leverages over 25 years of leadership in the medical device and healthcare industries. Before stepping into his current role, Redmond worked across engineering and health-tech, spanning start-ups (BiancaMed, duQuesne, The Design Consultancy, Elevre Medical), industry powerhouses (ResMed, Shanahan Engineering), and standardisation efforts with the NSAI (IEC and ISO), IEEE and CTA.

Having led clinical and engineering teams that delivered FDA and CE-cleared sleep and respiratory therapies, he excels at IP strategy, deep tech R&D, software lifecycle management, and clinical validation. His expertise in DSP, machine learning, and AI is reflected in the innovation processes he established for early-stage technologies, turning prototypes into regulatory-cleared commercial devices. With a robust background in corporate strategy, and commercialization, Redmond is dedicated to driving operational excellence and strategic growth at BlueDop Medical.

Ross Robinson

VP OF MEDICAL AFFAIRS

Ross Robinson brings over 20 years of clinical experience in podiatry, having worked across various leadership roles within the NHS and the private sector. His expertise includes managing high-risk diabetic patients, creating innovative clinical programs, and reducing patient waiting times. In addition, Ross has over 6 years of experience in the medical industry, where he has taken on roles such as EMEA Business Manager and Vice President of Medical Affairs. His industry experiences spans managing scientific communications, regulatory compliance, and medical content related to medical devices, as well as forging key relationships with healthcare professionals and industry leaders globally.

Board of Directors

Dr. Patrick Kelly

CO-FOUNDER & CHAIRMAN

Konstantin Mikhailov

NON-EXECUTIVE DIRECTOR

Declan Keane

NON-EXECUTIVE DIRECTOR

Harry Dorrance-King

NON-EXECUTIVE DIRECTOR